Company Profile
live
SmallNorthwest Biotherapeutics Capital Limited
09103328•Private Limited With Share Capital
C/O Clyde & Co Llp,,, St Botolph Building, 138 Houndsd, London, EC3A7AR
Get Full Access
Incorporated
26/06/2014
Company Age
12 years
Directors
1
Employees
—
SIC Code
68100
Risk
low risk
Company Overview
Registration, classification & business activity
Northwest Biotherapeutics Capital Limited (09103328) is a private limited with share capital incorporated on 26/06/2014 (12 years old) and registered in london, EC3A7AR. The company operates under SIC code 68100 - buying and selling of own real estate.
Private Limited With Share Capital
SIC: 68100
Small
Incorporated 26/06/2014
EC3A7AR
Financial Overview
Total Assets
£19.29M
Liabilities
£20.92M
Net Assets
£-1.63M
Est. Turnover
£2.17M
AI Estimated
Unreported
Cash
£41.4K
Key Metrics
1
Directors
1
Shareholders
Charges
5
Registered
4
Outstanding
0
Part Satisfied
1
Satisfied
Risk Assessment
low risk
International Score
Future Factor
fair
Performance Rating
Accounts
Typetotal exemption full
Due Date30/09/2026
Filing Date30/09/2025
Latest Accounts31/12/2024
Trading Addresses
The St. Botolph Building, 138 Houndsditch, London, EC3A7ARRegistered
Related Companies
2
Contact
C/O Clyde & Co Llp,,, St Botolph Building, 138 Houndsd, London, EC3A7AR